Related Experiment Videos
Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by
W Muschol1, G P Püschel, M Hülsmann
1Institut für Biochemie, Georg-August-Universität Göttingen, Federal Republic of Germany.
European Journal of Biochemistry
|March 14, 1991
Summary
Activated complement in rat serum significantly alters liver function, increasing glucose and lactate output and affecting blood flow. These effects are mediated by thromboxane and prostaglandins released from liver cells.
Area of Science:
- Biochemistry
- Physiology
- Immunology
Background:
- The complement system plays a crucial role in immune responses.
- Understanding complement's impact on liver function is vital for metabolic and hemodynamic research.
Purpose of the Study:
- To investigate the effects of complement-activated rat serum on isolated perfused rat liver metabolism and hemodynamics.
- To identify the specific mediators involved in these complement-induced alterations.
Main Methods:
- Isolated perfused rat liver model.
- Incubation of rat serum with zymosan to activate the complement system.
- Measurement of glucose and lactate output, and hepatic blood flow.
- Pharmacological inhibition using cyclooxygenase and lipoxygenase pathway inhibitors, and thromboxane/leukotriene antagonists.
Main Results:
- Complement-activated serum significantly increased glucose and lactate output and altered hepatic blood flow compared to control serum.
- These metabolic and hemodynamic changes were dose-dependent and largely abolished by heat inactivation of the serum.
- Effects were significantly inhibited by indomethacin (cyclooxygenase inhibitor) and BM 13505 (thromboxane antagonist), but less so by nordihydroguaiaretic acid and CGP 35949 B.
- Complement activation led to increased thromboxane B2 and prostaglandin F2 alpha in the hepatic vein.
Conclusions:
- Activated complement in rat serum influences liver metabolism and hemodynamics.
- This influence is mediated by the release of thromboxane and prostaglandins from non-parenchymal liver cells.
- These mediators, in turn, affect parenchymal liver cells, highlighting a complex intra-liver signaling pathway.